Taiho Oncology, Inc.
Maria Shah has a diverse work experience spanning across various industries and roles. Maria started their career as a Graduate Assistant in the Finance Department at Kean University Foundation Inc from September 2016 to May 2018. Following this, they joined BridgePointe Orthodontics as an Office Manager from September 2010 to March 2019. Concurrently, they also took up roles at Kean University as an Academic Specialist in the Office of Provost and Academic Affairs from August 2018 to March 2019, and later transitioned to the position of Assistant Director from March 2019 to August 2022. Currently, Maria is working at Taiho Oncology, Inc. as the Director of Strategic Planning in Medical Affairs, starting from August 2022.
Maria Shah has a Master of Business Administration (MBA) degree in Global Business Administration from Kean University. Maria also has a Bachelor of Science (B.S.) degree in Marketing, also from Kean University. Maria'seducation history includes attending Rutgers University - Newark, although the specific degree and field of study are not provided.
This person is not in any teams
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com